T cell polarization

T cell polarization is the fundamental biological process by which naive CD4+ T cells differentiate into specialized effector subsets, including Th1, Th2, Th17, and regulatory T cells (Tregs), based on the local cytokine environment and antigen-presenting cell (APC) interactions [2, 12]. This differentiation is orchestrated by specific signal transduction pathways, notably the JAK/STAT pathway, and the activation of 'master' transcription factors such as T-bet (Th1), GATA3 (Th2), RORγt (Th17), and FoxP3 (Treg) [9, 12]. Beyond lineage commitment, the term also describes the rapid physical reorganization of the T cell's cytoskeleton and secretory machinery toward the immunological synapse to ensure directed cytokine release and effective cell-cell communication [1, 4, 7]. Pathological polarization is central to various diseases: Th1 and Th17 dominance often drives autoimmune conditions like rheumatoid arthritis and multiple sclerosis, while Th2-skewed responses are associated with allergic diseases [12, 13]. In oncology, the induction of immunosuppressive Treg polarization within the tumor microenvironment facilitates immune evasion [3, 6]. Consequently, therapeutic strategies frequently target the molecular drivers of polarization, such as cytokines (e.g., IL-4, IL-12/23) or kinases (e.g., JAKs), to redirect the immune response and restore homeostasis [8, 10, 13].

Other names

T helper cell differentiationTh polarizationT cell lineage commitmentT cell functional specializationT cell polarity

Modulation of the cytokine-driven JAK/STAT signaling pathways and master transcription factors to shift the balance between pro-inflammatory and regulatory T cell subsets.